NCT06846385View on ClinicalTrials.gov

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

September 30, 2025

Conditions
Seasonal Allergic Rhinitis
Interventions
BIOLOGICAL

Placebo

A single dose was administered

BIOLOGICAL

MG-K10 Humanized Monoclonal Antibody Injection

MG-K10 Humanized Monoclonal Antibody Injection

Trial Locations (1)

100009

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Shanghai Mabgeek Biotech.Co.Ltd

OTHER_GOV